EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum



Pharmacokinetics and disposition of miltefosine in healthy mice and hamsters experimentally infected with Leishmania infantum



European Journal of Pharmaceutical Sciences



Miltefosine is the only currently available oral drug for treatment of leishmaniasis. However, information on the pharmacokinetics (PK) of miltefosine is relatively scarce in animals. PK parameters and disposition of the molecule was determined in healthy NMRI mice and Syrian hamsters infected and treated with different miltefosine doses and regimens. Long half-life of the molecule was confirmed and differential pattern of accumulation of the drug was observed in analyzed organs in mice and hamster. Long treatment schedules produced miltefosine levels over IC50 value against L. infantum intracellular amastigotes for at least 24 days in spleen and liver of infected hamsters. The observed differential pattern of organ accumulation of the drug in mice and hamster supports the relevance of both species for translational research on chemotherapy of leishmaniasis.

(PDF same-day service: $19.90)

Accession: 065402235

Download citation: RISBibTeXText

PMID: 29883726

DOI: 10.1016/j.ejps.2018.06.002



Related references

Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging. Plos Neglected Tropical Diseases 9(2): E0003556-E0003556, 2016

Amyloidosis in adrenal glands of hamsters experimentally infected with Leishmania infantum. Histology and Histopathology 5(2): 225-229, 1990

Histopathological studies of Syrian golden hamsters experimentally infected with Leishmania d. infantum. Journal of the Egyptian Society of Parasitology 27(3): 689-702, 1997

Histopathological studies of Syrian golden hamsters experimentally infected with Leishmania D. infantum. Journal of the Egyptian Society of Parasitology 27(3): 689-702, 1998

Renal changes in golden hamsters experimentally infected with Leishmania D. infantum on top of Schistosoma mansoni infection. Journal of the Egyptian Society of Parasitology 28(1): 183-189, 1998

Immunological pattern in Syrian golden hamsters experimentally infected with Schistosoma mansoni and Leishmania d. infantum. Journal of the Egyptian Society of Parasitology 27(2): 497-504, 1997

The histopathological picture of the liver of hamsters experimentally infected with Leishmania D. infantum on top of Schistosoma mansoni infection. Journal of the Egyptian Society of Parasitology 28(1): 101-117, 1998

Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis. Antimicrobial Agents and ChemoTherapy 54(11): 4699-4704, 2011

Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens. Journal of Antimicrobial ChemoTherapy 64(6): 1234-1240, 2010

The pathology of the heart and lung in Syrian golden hamsters experimentally infected with Leishmania d. infantum on top of pre-existing Schistosoma mansoni infection. Journal of the Egyptian Society of Parasitology 28(2): 395-402, 1998

Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Veterinary Parasitology 75(1): 33-40, 1998

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice. Memorias do Instituto Oswaldo Cruz 108(5): 623-630, 2014

Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum. Parasitology International 64(5): 295-298, 2016

Non-sand fly transmission of a North American isolate of Leishmania infantum in experimentally infected BALB/c mice. Journal of Parasitology 91(5): 1113-1115, 2006

Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum. Journal of Antimicrobial ChemoTherapy 71(7): 1914-1921, 2016